Skip to content

Clinical trials

Lung Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Italy Clear all

287 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20033
20045
20051
20066
20074
20087
20098
20105
20115
201210
201310
20149
201516
201610
201714
20189
201915
202014
202114
202220
202321
202421
202526
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126
Recruiting64
Unknown status40
Active, not recruiting27
Terminated20
Not yet recruiting4
Withdrawn4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals15
European Institute of Oncology13
AstraZeneca12
Bristol-Myers Squibb11
Eli Lilly and Company9
European Organisation for Research and Treatment of Cancer - EORTC9
Amgen7
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano7
Istituto Clinico Humanitas7
Pfizer7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms287
Carcinoma, Non-Small-Cell Lung122
Neoplasms41
Breast Neoplasms26
Lung Diseases20
Colorectal Neoplasms17
Head and Neck Neoplasms17
Neoplasm Metastasis17
Carcinoma16
Adenocarcinoma of Lung15

Trials

Showing 51 to 75 of 287. Each trial links to its page on Pharma Observatory.

187 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.